Summary
Johnson & Johnson (JNJ) filed an 8-K on January 24, 2017, to report its fourth quarter and full year financial results for the period ending January 1, 2017. The filing primarily consists of a press release and supplementary financial data. While specific financial figures like revenue, net income, and EPS are not detailed in the provided excerpt, investors should note that this report serves as the official release of these key performance indicators. The accompanying press release and supplementary data offer a comprehensive look at the company's performance for the reported periods, enabling investors to assess trends, profitability, and overall financial health.
Key Highlights
- 1Johnson & Johnson (JNJ) released its Q4 and Full Year 2016 financial results via an 8-K filing on January 24, 2017.
- 2The report includes a press release and unaudited comparative supplementary sales data and condensed consolidated statements of earnings.
- 3The filing covers the fourth quarter and the full fiscal year ended January 1, 2017.
- 4This 8-K officially disseminates the company's sales and earnings performance for the reported periods.
- 5Investors can find detailed financial performance metrics within the attached exhibits (Press Release and Supplementary Data).
- 6The filing allows for an assessment of JNJ's operational performance and financial condition as of early 2017.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially announce and provide Johnson & Johnson's (JNJ) sales and earnings results for the fourth quarter and the full fiscal year ended January 1, 2017, to the public and investors.
This filing includes a press release and unaudited comparative supplementary sales data along with condensed consolidated statements of earnings. These documents contain detailed information on JNJ's sales and earnings performance for the fourth quarter and the full year.
Johnson & Johnson reported these results on January 24, 2017, for the period ending January 1, 2017.
The actual financial numbers are contained within the exhibits attached to this 8-K filing, specifically Exhibit 99.15 (Press Release) and Exhibit 99.2O (Unaudited Comparative Supplementary Sales Data and Condensed Consolidated Statement of Earnings).